IL6 and acute respiratory distress syndrome: A similar approach to subtyping patients with COVID-19 ARDS early in the pandemic revealed significant overlap with non-COVID ARDS subtypes, but with the exception of IL-6, data on biomarkers of lung injury and inflammation were unavailable [25].